Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GJB2 | P29033 | 4/20 | 0.46 |
| ▸ | SSTR1 | P30872 | 5/20 | 0.44 |
| ▸ | SSTR2 | P30874 | 5/20 | 0.44 |
| ▸ | SSTR4 | P31391 | 5/20 | 0.44 |
| ▸ | SSTR3 | P32745 | 5/20 | 0.44 |
| ▸ | SSTR5 | P35346 | 5/20 | 0.44 |
| ▸ | FGF1 | P05230 | 3/20 | 0.44 |
| ▸ | FGF2 | P09038 | 3/20 | 0.44 |
| ▸ | VEGFA | P15692 | 3/20 | 0.44 |
| ▸ | HPSE | Q9Y251 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | TNF | P01375 | 1/20 | 0.41 |
| ▸ | GBA1 | P04062 | 1/20 | 0.41 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.38 |
| ▸ | TACR1 | P25103 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5985705 | 1.00 | GJB2 (0.46) | GJB2SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL11666500 | 1.00 | GJB2 (0.46) | GJB2SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL11666504 | 1.00 | GJB2 (0.46) | GJB2SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL2059654 | 0.98 | SSTR1 (0.46) | GJB2SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL2059653 | 0.98 | SSTR1 (0.46) | GJB2SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL18333049 | 0.93 | GJB2 (0.45) | GJB2SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL18332876 | 0.93 | GJB2 (0.45) | GJB2SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL14670875 | 0.93 | GJB2 (0.45) | GJB2SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL16374731 | 0.93 | GJB2 (0.45) | GJB2SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL21080964 | 0.91 | SSTR1 (0.46) | GJB2SSTR1SSTR2SSTR4SSTR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1634888-A2 | Synthesis of 2'-deoxy-L-nucleosides | Pharmasset Limited (US) | 2006-03-15 | — | — | EP | disclosed |
| EP-1600451-A2 | Synthesis of 2'-deoxy-l-nucleosides | Pharmasset Limited (US) | 2005-11-30 | — | — | EP | disclosed |
| EP-1600452-A2 | Synthesis of 2'-deoxy-L-nucleosides | Pharmasset Limited (US) | 2005-11-30 | — | — | EP | disclosed |
| US-20050090660-A1 | 2'-deoxy-L-nucleosides | PHARMASSET, INC. | 2005-04-28 | — | — | US | disclosed |
| EP-1232166-A2 | SYNTHESIS OF 2'-DEOXY-L-NUCLEOSIDES | Pharmasset Limited (US) | 2002-08-21 | — | — | EP | disclosed |
| WO-2001034618-A2 | SYNTHESIS OF 2'-DEOXY-L-NUCLEOSIDES | PHARMASSET LIMITED (US) | 2001-05-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050090660-A1 | 2'-deoxy-L-nucleosides | CCNH, ADAR, NSUN2 | GJB2 3377/4885SSTR1 2000/4885SSTR2 1751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.